The Alexander Shulgin Research Institute continues the work of Sasha Shulgin. It’s somewhat similar in mission/topic as Isomer Design.
Alexander Shulgin Research Institute
“The mission of the Alexander Shulgin Research Institute is to preserve and continue the work of seminal biochemist Sasha Shulgin, by performing basic biochemistry and neuroscience research; providing support services to toxicologists, emergency room doctors, attorneys, chemists, and other scientists and professionals; and conserving and disseminating 50 years of existing research.”
The last post on the website dates from November 2017.
Company Information
Alexander Shulgin Research Institute Website
Founded
January, 2011
Operational
No
Ended
April, 2024
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Company News
Noetic Commits to Investing $6.95M into Seed Round for The Alexander Shulgin Research Institute for Psychedelic Drug Discovery and Development (Press Release, 09 December 2021)In December 2019, Noetic led the seed round for the Alexander Shulgin Research Institute, funding it to the tune of $6.95 million.
The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of (Motherboard, 24 January 2022)
This article, by the always excellent Shayla Love, discussed the next generation of novel psychedelics. Starting with the many discoveries of Sasha Shulgin, the article then dives deeper into the wishes and hopes of psychedelic companies.